Newsfeeds - Spark Newswire

3 minute read

The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics’ Tebipenem, Graybug Reviews Strategic Alternatives

By Vandana Singh

Today, 7:35 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ALPMF

1 minute read

Sutro Biopharma Stock Surges On Cancer Treatment Pact

By Vandana Singh

Today, 7:35 PM

Astellas Pharma Inc (OTC: ALPMF) and Sutro Biopharma Inc (NASDAQ:STRO) announced a strategic collaboration and licensing agreement focused on the discovery and development of…

ALPMF

3 minute read

Astellas and Sutro Biopharma Announced Worldwide Strategic Collaboration on Monday to Advance Novel Immunostimulatory Antibody-Drug Conjugates; Sutro to Receive an Upfront Payment of $90M Plus Up to $422.5M in Milestones, Plus Royalties

By Charles Gross

Today, 7:35 PM

Astellas Pharma Inc. (TSE: 4503), (President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Sutro Biopharma, Inc. (NASDAQ: STRO), (CEO: William J.

STRO

2 minute read

Earnings

Sutro Biopharma’s Return On Capital Employed Insights

By Benzinga Insights

Today, 7:35 PM

Sutro Biopharma (NASDAQ:STRO) brought in sales totaling $5.90 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 2.58%, resulting in a loss of $39.11 million.

STRO